The report highlights Astellas' commitment to achieving the goals set in Corporate Strategic Plan 2021 (CSP2021), including the launch of new products like VEOZAH, the acquisition of Iveric Bio, and the progress made in implementing its Sustainability Direction. The report also details Astellas' efforts to foster a corporate culture that encourages innovation, talent development, and collaboration.
Issuing Company Astellas Pharma Inc.
Report Type Integrated Report
Report Language EN
Report Filesize 10.46 MB
No. of Pages 100 pages
Reporting periodApril 1, 2022-March 31, 2023
Report EditionUnknown
Assurance Provider Unknown
Reporting Standards GRI; SASB; UNSDGs
Materiality Assessmenttrue